1.47 USD
↗ 0.02 (1.10%)PRE MARKET (AS OF 04:02 AM EDT)
Invivyd, Inc. Common Stock
IVVDNASDAQ • USD
Market: OPEN
Open?$1.48
High?$1.48
Low?$1.48
Prev. Close?$1.46
Volume?301
Avg. Volume?3.4M
VWAP?$1.48
Rel. Volume?0.00x
Bid / Ask
Bid?$1.28 × 100
Ask?$1.70 × 100
Spread?$0.42
Midpoint?$1.49
Valuation & Ratios
Market Cap?412.9M
Shares Out?282.8M
Float?155.5M
Float %?66.7%
P/E Ratio?N/A
P/B Ratio?1.71
EPS?-$0.19
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?7.24Strong
Quick Ratio?7.24Strong
Cash Ratio?6.64Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score75/100
P/E?N/A▾
P/B?1.71CHEAP▾
P/S?7.73HIGH▾
P/FCF?N/A▾
EV/EBITDA?-3.4CHEAP▾
EV/Sales?3.49FAIR▾
Returns & Efficiency
ROE?-21.7%WEAK▾
ROA?-19.0%WEAK▾
Cash Flow & Enterprise
FCF?$-58290000
Enterprise Value?$186.2M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
Employees
122
Market Cap
412.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-08-06
Address
209 CHURCH STREET
NEW HAVEN, CT 06510
Phone: (781) 819-0080
NEW HAVEN, CT 06510
Phone: (781) 819-0080